Clinical trials
Anemia, Sickle Cell trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2013 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 6 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 8 |
| Active, not recruiting | 3 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitari Vall d'Hebron Research Institute | 6 |
| Novartis Pharmaceuticals | 5 |
| Novo Nordisk A/S | 3 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| Agios Pharmaceuticals, Inc. | 1 |
| Cyprus Institute of Neurology and Genetics | 1 |
| Forma Therapeutics, Inc. | 1 |
| Mast Therapeutics, Inc. | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 23 |
| Anemia | 6 |
| Thalassemia | 6 |
| Hemoglobinopathies | 5 |
| Vaso-Occlusive Crises | 5 |
| Hematologic Diseases | 3 |
| alpha-Thalassemia | 3 |
| beta-Thalassemia | 3 |
| COVID-19 | 2 |
| Hemolysis | 2 |
Trials
Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.